FDA Adverse Event Injury Summary report: N

GENESIS XP DUAL 4-CHANNEL IPG

MDR report key: 1834116 · Received September 13, 2010

Report

Report Number
1627487-2010-02010
Event Type
Injury
Date Received
September 13, 2010
Date of Event
September 14, 2007
Report Date
September 20, 2007
Manufacturer
ADVANCED NEUROMODULATION SYSTEMS
Product Code
LGW
PMA / PMN Number
P010032
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

EVAL: THE DEVICE HISTORY AND STERILIZATION RECORDS WERE REVIEWED. RESULTS: THE DEVICE HISTORY AND STERILIZATION RECORDS REVIEWED WERE FOUND TO MEET SPECS AND NO ANOMALIES WERE FOUND. CONCLUSION: THE CAUSE OF THE REPORTED COMPLAINT COULD NOT BE DETERMINED FROM THE REVIEW OF THE DHR AND STERILIZATION RECORDS. THIS MDR IS BEING SUBMITTED PAST THE 30 DAY REPORTING REQUIREMENT AS PART OF A RETROSPECTIVE REVIEW INITIATED IN RESPONSE TO AN FDA INSPECTION. A RETROSPECTIVE REVIEW OF THE COMPLAINT RECORD DETERMINED THAT ANS MISINTERPRETED THE MDR REGULATIONS IN THIS INSTANCE. ANS HAS LIMITED INFO RELATED TO THE PT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PT'S HISTORY TO THE EVENT REPORTED. ANS DEFERS TO THE PT'S PHYSICIAN REGARDING MEDICAL HISTORY.

Description of Event or Problem · 1

THE PT RECEIVED HER SCS SYSTEM ON (B)(6)2005. IT WAS REPORTED THAT STIMULATION WOULD CEASE EVERY DAY WITHOUT A KNOWN REASON AND TURNS BACK ON AFTER A FEW SECONDS, CAUSING OVERSTIMULATION IN THE PROCESS. IT WAS ALSO REPORTED THAT THE PT FELT UNDESIRED STIMULATION AROUND THE IPG POCKET SITE AS WELL. THE IPG WAS REPLACED ON (B)(6)2007. FOLLOW UP ON THE PT FOUND THAT NO FURTHER ISSUES HAVE BEEN REPORTED. THE EXPLANTED IPG WAS RETURNED TO ANS FOR EVAL. NO FURTHER INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GENESIS XP DUAL 4-CHANNEL IPG TOTALLY IMPLANTABLE PULSE GENERATOR LGW ADVANCED NEUROMODULATION SYSTEMS 3644 34983A

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention